Related Experiment Video

Updated: Jun 19, 2026

Cell Population Analyses During Skin Carcinogenesis
06:53

Cell Population Analyses During Skin Carcinogenesis

Published on: August 21, 2013

MK2 regulates the early stages of skin tumor promotion

Claus Johansen1, Christian Vestergaard, Knud Kragballe

  • 1Department of Dermatology, Aarhus University Hospital, P.P. Oerumsgade 11, 8000 Aarhus, Denmark.

Carcinogenesis
|October 8, 2009
PubMed

Insights

Mitogen-activated protein kinase-activated protein kinase-2 (MK2) deficiency reduces skin tumor development by regulating inflammation and apoptosis. MK2 plays a dual role in early tumor promotion, making it a potential therapeutic target for skin carcinoma.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Inflammation and tumorigenesis are closely linked.
  • Mitogen-activated protein kinase-activated protein kinase-2 (MK2) is crucial in inflammatory pathways.
  • Understanding MK2's role in skin cancer is vital for therapeutic development.

Purpose of the Study:

  • To investigate the role of MK2 and tumor necrosis factor (TNF)-alpha in skin tumor development.
  • To elucidate the mechanisms by which MK2 influences carcinogenesis, focusing on inflammation and apoptosis.

Main Methods:

  • Utilized a two-stage chemical carcinogenesis model in mice (DMBA initiation, TPA promotion).
  • Compared skin tumor development in wild-type, MK2-deficient (MK2(-/-)), and TNF-alpha-deficient (TNF-alpha(-/-)) mice.
  • Assessed inflammatory responses, epidermal apoptosis, p53 levels, and MDM2 phosphorylation in vitro and in vivo.

Main Results:

  • MK2(-/-) mice exhibited significantly fewer skin tumors than wild-type and TNF-alpha(-/-) mice.
  • Reduced inflammatory response was observed in MK2(-/-) and TNF-alpha(-/-) mice, but tumorigenesis inhibition was more pronounced in MK2(-/-) mice.
  • MK2 deficiency led to increased epidermal apoptosis, elevated p53 levels, and reduced MDM2 activation, suggesting a role in DNA damage response.

Conclusions:

  • MK2 plays a dual role in early skin tumor promotion by modulating both inflammation and apoptosis of DNA-damaged cells.
  • MK2 deficiency inhibits skin carcinogenesis through mechanisms beyond just reducing inflammation.
  • MK2 emerges as a potential therapeutic target for skin carcinoma treatment.

More Related Videos

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)04:12

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)

Published on: December 19, 2019

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells06:09

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

Published on: June 7, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...